Defence Therapeutics Aligns Accum ADC Strategy Through Multidisciplinary Scientific Advisory Board Life Science Investing
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026 Life Science Investing
Nektar to Hold Conference Call to Discuss Topline Results from the 36-Week Maintenance Period for its REZOLVE-AD Phase 2b Study of Rezpegaldesleukin in Atopic Dermatitis on February 10, 2026 Life Science Investing
Praxis Precision Medicines to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 19, 2026, and Participate in Upcoming Investor Conferences Life Science Investing
XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc. Life Science Investing
Entera Bio Appoints Former Pfizer Executive Geno J. Germano as Chairman of the Board Ahead of Key Milestones Life Science Investing
EraNova Metals Identifies Rare Earth Element Potential at Adanac Through Re-Evaluation of Existing Assay Data; Announces Investor Relations Agreement; Announces Stock Option Grant Life Science Investing
Anavex Life Sciences Reports Fiscal 2026 First Quarter Financial Results and Provides Business Update Life Science Investing
BeyondSpring to Participate at the 12th Annual Immuno-Oncology 360° Conference Life Science Investing
